These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7864717)

  • 1. Heart failure: an update on pathophysiology.
    Drexler H
    Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():13-6. PubMed ID: 7864717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral adaptation in chronic heart failure: therapeutic implications].
    Drexler H
    Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of myocardial sarcoplasmic reticulum Ca(++)-ATPase in cardiac hypertrophy by angiotensin converting enzyme?
    Holtz J; Studer R; Reinecke H; Just H; Drexler H
    Basic Res Cardiol; 1992; 87 Suppl 2():191-204. PubMed ID: 1338565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of myocardial hypertrophy in heart failure].
    Holtz J
    Z Kardiol; 1992; 81 Suppl 4():41-8. PubMed ID: 1290305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
    Münzel T; Kurz S; Drexler H
    Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade.
    Zierhut W; Studer R; Laurent D; Kästner S; Allegrini P; Whitebread S; Cumin F; Baum HP; de Gasparo M; Drexler H
    Cardiovasc Res; 1996 May; 31(5):758-68. PubMed ID: 8763405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Arzneimittelforschung; 1994 Mar; 44(3A):455-8. PubMed ID: 8185723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasticity of myocardial phenotype during cardiac hypertrophy and failure].
    Mercadier JJ; Lompre AM; Swynghedauw B; Schwartz K
    Bull Acad Natl Med; 1993 Jun; 177(6):917-31; discussion 931-3. PubMed ID: 8221190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition.
    Coirault C; Langeron O; Lambert F; Blanc FX; Lerebours G; Claude N; Riou B; Chemla D; Lecarpentier Y
    J Pharmacol Exp Ther; 1999 Oct; 291(1):70-5. PubMed ID: 10490888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure.
    Drexler H; Kurz S; Jeserich M; Münzel T; Hornig B
    Am J Cardiol; 1995 Nov; 76(15):13E-18E. PubMed ID: 7484881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiocirculatory dynamics in the normal and failing heart.
    Zelis R; Flaim SF; Liedtke AJ; Nellis SH
    Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.